Adverse events26

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 26

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Constipation	Gastrointestinal disorders	Melphalan, Dexamethasone, Bortezomib,	2	35	2
other	Hemoglobin	Blood and lymphatic system disorders	Melphalan, Dexamethasone, Bortezomib,	2	35	2
serious	Death	General disorders	Melphalan, Dexamethasone, Bortezomib,	2	35	2
serious	Infection with Normal ANC-Lung (pneumonia)	Infections and infestations	Melphalan, Dexamethasone, Bortezomib,	2	35	2
serious	Pain-chest wall	General disorders	Melphalan, Dexamethasone, Bortezomib,	1	35	1
serious	Congestive Heart Failure	Cardiac disorders	Melphalan, Dexamethasone, Bortezomib,	1	35	1
serious	Dehydration	Gastrointestinal disorders	Melphalan, Dexamethasone, Bortezomib,	2	35	2
serious	Hyperglycemia	Metabolism and nutrition disorders	Melphalan, Dexamethasone, Bortezomib,	1	35	1
serious	Hyponatremia	Metabolism and nutrition disorders	Melphalan, Dexamethasone, Bortezomib,	1	35	1
serious	Mental Status Change	Psychiatric disorders	Melphalan, Dexamethasone, Bortezomib,	2	35	2
serious	Hypotension	Cardiac disorders	Melphalan, Dexamethasone, Bortezomib,	1	35	1
serious	Nausea	Gastrointestinal disorders	Melphalan, Dexamethasone, Bortezomib,	1	35	1
serious	Vomiting	Gastrointestinal disorders	Melphalan, Dexamethasone, Bortezomib,	1	35	1
serious	thrombocytopenia	Blood and lymphatic system disorders	Melphalan, Dexamethasone, Bortezomib,	2	35	2
serious	Creatinine	Metabolism and nutrition disorders	Melphalan, Dexamethasone, Bortezomib,	2	35	2
serious	Ventricular Arrhythmia	Cardiac disorders	Melphalan, Dexamethasone, Bortezomib,	2	35	2
serious	Edema	Blood and lymphatic system disorders	Melphalan, Dexamethasone, Bortezomib,	2	35	2
serious	Dyspnea	Respiratory, thoracic and mediastinal disorders	Melphalan, Dexamethasone, Bortezomib,	2	35	2
serious	Hypoxia	Respiratory, thoracic and mediastinal disorders	Melphalan, Dexamethasone, Bortezomib,	2	35	2
serious	syncope	Nervous system disorders	Melphalan, Dexamethasone, Bortezomib,	1	35	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00520767/events

API reference For AI assistants

Adverse events26

Sources 3

Read this list from software.